Full Text View
Tabular View
No Study Results Posted
Related Studies
Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients
This study has been completed.
Study NCT00225394   Information provided by University of Massachusetts, Worcester

First Received on September 21, 2005.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
CMV Disease
Viral Resistance
Rejection
Death
Additional drug interventions recognized in this trial
Ganciclovir
Valganciclovir
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Massachusetts, Worcester
Beth Israel Deaconess Medical Center
Lahey Clinic
Rhode Island Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services